GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Respiratorius AB (XSAT:RESP) » Definitions » Momentum Rank

Respiratorius AB (XSAT:RESP) Momentum Rank : 0 (As of May. 25, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Respiratorius AB Momentum Rank?

Respiratorius AB has the Momentum Rank of 0.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Respiratorius AB Momentum Rank Related Terms

Thank you for viewing the detailed overview of Respiratorius AB's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Respiratorius AB (XSAT:RESP) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Respiratorius AB (XSAT:RESP) » Definitions » Momentum Rank
Comparable Companies
OSTO:ANNX OSTO:BIOSGN XSAT:DEX XSAT:WNT OSTO:XINT NGM:COEGIN XSAT:ABERA OSTO:COMBI OSTO:EXPRS2 OSTO:SCOL OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
HF0:Germany
Address
Scheelevagen 2, Medicon Village, Lund, SWE, 223 81
Website
https://www.respiratorius.com
Respiratorius AB develops pharmaceutical drugs to treat the common diseases namely Cancer, Chronic Obstructive Pulmonary Disease (COPD), and asthma as well as better methods for diagnosing cardiovascular diseases. The company's drug candidates includes RCD405, VAL001, RESP2000, RESP3000, RESP9000, and RESP1000.

Respiratorius AB (XSAT:RESP) Headlines

No Headlines